Cabral MDI, Liu S, Soares N (2019) Attention-deficit/hyperactivity disorder: diagnostic criteria, epidemiology, risk factors and evaluation in youth. Translational Pediatrics:S104-S113

Cortese S (2020) Pharmacologic treatment of attention deficit-hyperactivity disorder. N Engl J Med 383(11):1050–1056

Article  CAS  PubMed  Google Scholar 

Wigal SB (2009) Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults. CNS Drugs 23:21–31

Article  CAS  PubMed  Google Scholar 

Faraone SV, Asherson P, Banaschewski T, Biederman J, Buitelaar JK, Ramos-Quiroga JA, Rohde LA, Sonuga-Barke EJ, Tannock R, Franke B (2015) Attention-deficit/hyperactivity disorder. Nat Rev Dis Primers 1(15020

Renoux C, Shin JY, Dell’Aniello S, Fergusson E, Suissa S (2016) Prescribing trends of attention-deficit hyperactivity disorder (ADHD) medications in UK primary care, 1995–2015. Br J Clin Pharmacol 82(3):858–868

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raman SR, Man KKC, Bahmanyar S, Berard A, Bilder S, Boukhris T, Bushnell G, Crystal S, Furu K, KaoYang YH, Karlstad Ø, Kieler H, Kubota K, Lai EC, Martikainen JE, Maura G, Moore N, Montero D, Nakamura H, Neumann A, Pate V, Pottegård A, Pratt NL, Roughead EE, Saint-Gerons M, Stürmer D, Su T, Zoega CC, Sturkenbroom H, Chan M, Coghill EW, Ip D, Wong P ICK (2018) Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases. Lancet Psychiatry 5(10):824–835

Article  PubMed  Google Scholar 

Storebø OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog M, Holmskov M, Rosendal S, Groth C, Magnusson FL, Moreira-Maia CR, Gillies D, Buch Rasmussen K, Gauci D, Zwi M, Kirubakaran R, Forsbøl B, Simonsen E, Gluud C (2015) Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database Syst Rev 2015(11):Cd009885

Chang Z, Ghirardi L, Quinn PD, Asherson P, D’Onofrio BM, Larsson H (2019) Risks and benefits of attention-deficit/hyperactivity disorder medication on behavioral and neuropsychiatric outcomes: a qualitative review of pharmacoepidemiology studies using linked prescription databases. Biol Psychiatry 86(5):335–343

Article  PubMed  PubMed Central  Google Scholar 

Cortese S, Adamo N, Del Giovane C, Mohr-Jensen C, Hayes AJ, Carucci S, Atkinson LZ, Tessari L, Banaschewski T, Coghill D, Hollis C, Simonoff E, Zuddas A, Barbui C, Purgato M, Steinhausen HC, Shokraneh F, Xia J, Cipriani A (2018) Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry 5(9):727–738

Article  PubMed  PubMed Central  Google Scholar 

Fay TB, Alpert MA (2019) Cardiovascular effects of drugs used to treat Attention-Deficit/Hyperactivity disorder part 2: impact on cardiovascular events and recommendations for evaluation and monitoring. Cardiol Rev 27(4):173–178

Article  PubMed  Google Scholar 

Torres-Acosta N, O’Keefe JH, O’Keefe CL, Lavie CJ (2020) Cardiovascular effects of ADHD therapies: JACC review topic of the week. J Am Coll Cardiol 76(7):858–866

Article  CAS  PubMed  Google Scholar 

Kelly AS, Rudser KD, Dengel DR, Kaufman CL, Reiff MI, Norris AL, Metzig AM, Steinberger J (2014) Cardiac autonomic dysfunction and arterial stiffness among children and adolescents with attention deficit hyperactivity disorder treated with stimulants. J Pediatr 165(4):755–759

Article  PubMed  PubMed Central  Google Scholar 

Zhang L, Yao H, Li L, Du Rietz E, Andell P, Garcia-Argibay M, D’Onofrio BM, Cortese S, Larsson H, Chang Z (2022) Risk of cardiovascular diseases associated with medications used in Attention-Deficit/Hyperactivity disorder: a systematic review and meta-analysis. JAMA Netw Open 5(11):e2243597

Article  PubMed  PubMed Central  Google Scholar 

Man KKC, Häge A, Banaschewski T, Inglis SK, Buitelaar J, Carucci S, Danckaerts M, Dittmann RW, Falissard B, Garas P, Hollis C, Konrad K, Kovshoff H, Liddle E, McCarthy S, Neubert A, Nagy P, Rosenthal E, Sonuga-Barke EJS, Zuddas A, Wong ICK, Coghill D (2023) Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the attention deficit hyperactivity disorder drugs use chronic effects (ADDUCE) study. Lancet Psychiatry 10(5):323–333

Article  PubMed  Google Scholar 

Zhang L, Li L, Andell P, Garcia-Argibay M, Quinn PD, D’Onofrio BM, Brikell I, Kuja-Halkola R, Lichtenstein P, Johnell K, Larsson H, Chang Z (2024) Attention-deficit/hyperactivity disorder medications and long-term risk of cardiovascular diseases. JAMA Psychiat 81(2):178–187

Article  Google Scholar 

(2019) National Institute for Health and Care Excellence: Guidelines. In: Attention deficit hyperactivity disorder: diagnosis and management. National Institute for Health and Care Excellence (NICE) Copyright © NICE 2018., London

Wolraich ML, Hagan JF Jr., Allan C, Chan E, Davison D, Earls M, Evans SW, Flinn SK, Froehlich T, Frost J, Holbrook JR, Lehmann CU, Lessin HR, Okechukwu K, Pierce KL, Winner JD, Zurhellen W (2019) Clinical practice guideline for the Diagnosis, Evaluation, and treatment of Attention-Deficit/Hyperactivity disorder in children and adolescents. Pediatrics 144(4)

Hsieh CY, Su CC, Shao SC, Sung SF, Lin SJ, Kao Yang YH, Lai EC (2019) Taiwan’s national health insurance research database: past and future. Clin Epidemiol 11:349–358

Article  PubMed  PubMed Central  Google Scholar 

Hsieh CY, Chen CH, Li CY, Lai ML (2015) Validating the diagnosis of acute ischemic stroke in a National health insurance claims database. J Formos Med Assoc 114(3):254–259

Article  PubMed  Google Scholar 

Sung SF, Hsieh CY, Lin HJ, Chen YW, Yang YH, Li CY (2016) Validation of algorithms to identify stroke risk factors in patients with acute ischemic stroke, transient ischemic attack, or intracerebral hemorrhage in an administrative claims database. Int J Cardiol 215:277–282

Article  PubMed  Google Scholar 

Farrington P, Whitaker H, Ghebremichael Weldeselassie Y (2018) Self-Controlled case series studies: A modelling guide with R, 1st edn. Chapman and Hall/CRC

Houghton R, de Vries F, Loss G (2020) Psychostimulants/Atomoxetine and serious cardiovascular events in children with ADHD or autism spectrum disorder. CNS Drugs 34(1):93–101

Article  CAS  PubMed  Google Scholar 

Olfson M, Huang C, Gerhard T, Winterstein AG, Crystal S, Allison PD, Marcus SC (2012) Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 51(2):147–156

Article  PubMed  Google Scholar 

Shin JY, Roughead EE, Park BJ, Pratt NL (2016) Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study. BMJ 353:i2550

Article  PubMed  PubMed Central  Google Scholar 

Li L, Chang Z, Sun J, Garcia-Argibay M, Du Rietz E, Dobrosavljevic M, Brikell I, Jernberg T, Solmi M, Cortese S, Larsson H (2022) Attention-deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population-based cohort study. World Psychiatry 21(3):452–459

Article  PubMed  PubMed Central  Google Scholar 

Jeong HE, Lee H, Lai EC, Liao TC, Man KKC, Wong ICK, Coghill D, Chi MH, Hsieh CY, Shin JY (2021) Association between methylphenidate and risk of myocardial infarction: a multinational self-controlled case series study. Pharmacoepidemiol Drug Saf 30(10):1458–1467

Article  CAS  PubMed  Google Scholar 

Schelleman H, Bilker WB, Strom BL, Kimmel SE, Newcomb C, Guevara JP, Daniel GW, Cziraky MJ, Hennessy S (2011) Cardiovascular events and death in children exposed and unexposed to ADHD agents. Pediatrics 127(6):1102–1110

Article  PubMed  PubMed Central  Google Scholar 

Samuels JA, Franco K, Wan F, Sorof JM (2006) Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial. Pediatr Nephrol 21(1):92–95

Article  PubMed  Google Scholar 

Petersen I, Douglas I, Whitaker H (2016) Self controlled case series methods: an alternative to standard epidemiological study designs. BMJ 354:i4515

Article  PubMed  Google Scholar 

Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML (2011) Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 20(3):236–242

Article  PubMed  Google Scholar 

Cheng CL, Lee CH, Chen PS, Li YH, Lin SJ, Yang YH (2014) Validation of acute myocardial infarction cases in the National health insurance research database in Taiwan. J Epidemiol 24(6):500–507

Article  PubMed  PubMed Central  Google Scholar